Clinical and Diagnostic Laboratory Immunology, January 2004, p. 1-5, Vol. 11, No. 1
1071-412X/04/$08.00+0 DOI: 10.1128/CDLI.11.1.1-5.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
Assignment of Neisseria meningitidis Serogroups A, C, W135, and Y Anticapsular Total Immunoglobulin G (IgG), IgG1, and IgG2 Concentrations to Reference Sera
Helen Joseph,1* Paul Balmer,1 Mike Bybel,2 Thomas Papa,2 Robert Ryall,2 and Ray Borrow1
Vaccine Evaluation Department, Manchester Medical Microbiology Partnership, Manchester Royal Infirmary, Manchester M13 9WZ, United Kingdom,1
Aventis Pasteur, Discovery Drive, Swiftwater, Pennsylvania2
Received 22 July 2003/
Returned for modification 21 August 2003/
Accepted 25 September 2003
Meningococcal serogroup-specific immunoglobulin G (IgG), IgG1, and IgG2 concentrations were assigned to three reference sera, CDC 1992, 89-SF, and 96/562, for meningococcal serogroups A, C, Y, and W135 via the method of cross standardization. The sum of the serogroup-specific IgG1 and IgG2 concentrations determined for the four meningococcal serogroups showed good agreement with the serogroup-specific IgG either determined here or as previously represented. Following the assignment of meningococcal serogroup-specific IgG1 and IgG2 concentration to these reference sera, a meningococcal serogroup-specific IgG1 and IgG2 enzyme-linked immunosorbent assay protocol was developed. The serogroup A and C specific subclass distribution of a panel of adult sera collected following vaccination with any combination of meningococcal serogroup C conjugate, bivalent, or tetravalent polysaccharide vaccines was determined. For the determination of serogroup W135 and Y specific subclass distribution, an adolescent panel 28 days following a single dose of either tetravalent polysaccharide or conjugate vaccine was used. The sum of the serogroup-specific IgG1 and IgG2 showed strong correlation with the serogroup-specific total IgG determined. The assignment here of IgG1 and IgG2 subclasses to these reference sera will allow more detailed evaluation of meningococcal conjugate and polysaccharide vaccines.
* Corresponding author. Mailing address: Vaccine Evaluation Department, Manchester Medical Microbiology Partnership, P.O. Box 209, Clinical Sciences Building, Manchester Royal Infirmary, Manchester, M13 9WZ, United Kingdom. Phone: 44 161 2766793. Fax: 44 161 2766792. E-mail: helen.joseph{at}hpa.org.uk.
Clinical and Diagnostic Laboratory Immunology, January 2004, p. 1-5, Vol. 11, No. 1
1071-412X/04/$08.00+0 DOI: 10.1128/CDLI.11.1.1-5.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Huo, Z., Sinha, R., McNeela, E. A., Borrow, R., Giemza, R., Cosgrove, C., Heath, P. T., Mills, K. H. G., Rappuoli, R., Griffin, G. E., Lewis, D. J. M.
(2005). Induction of Protective Serum Meningococcal Bactericidal and Diphtheria-Neutralizing Antibodies and Mucosal Immunoglobulin A in Volunteers by Nasal Insufflations of the Neisseria meningitidis Serogroup C Polysaccharide-CRM197 Conjugate Vaccine Mixed with Chitosan. Infect. Immun.
73: 8256-8265
[Abstract]
[Full Text]
-
Giardina, P. C., Longworth, E., Evans-Johnson, R. E., Bessette, M. L., Zhang, H., Borrow, R., Madore, D., Fernsten, P.
(2005). Analysis of Human Serum Immunoglobulin G against O-Acetyl-Positive and O-Acetyl-Negative Serogroup W135 Meningococcal Capsular Polysaccharide. CVI
12: 586-592
[Abstract]
[Full Text]
-
Al-Mazrou, Y., Khalil, M., Borrow, R., Balmer, P., Bramwell, J., Lal, G., Andrews, N., Al-Jeffri, M.
(2005). Serologic Responses to ACYW135 Polysaccharide Meningococcal Vaccine in Saudi Children under 5 Years of Age. Infect. Immun.
73: 2932-2939
[Abstract]
[Full Text]
Copyright © 2004 by the American Society for Microbiology. All rights reserved.